UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

A nested case-control study on dietary fat consumption and the risk for gallstone disease

Journal of human nutrition and dietetics, 2016-06, Vol.29 (3), p.338-344

2016

Volltextzugriff (PDF)

Gamma Knife Radiosurgery in the management of single and multiple brain metastases

Clinical neurology and neurosurgery, 2016-02, Vol.141, p.43-47

2016

Volltextzugriff (PDF)

Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome

AIDS (London), 2004-01, Vol.18 (2), p.237-245

2004

Volltextzugriff (PDF)

Sex differences among subcutaneous implantable cardioverter-defibrillator recipients: a propensity-matched, multicentre, international analysis from the i-SUSI project

Europace (London, England), 2024-05, Vol.26 (5)

2024

Volltextzugriff (PDF)

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial

Clinical infectious diseases, 2009-11, Vol.49 (9), p.1441-1449

2009

Volltextzugriff (PDF)

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

The New England journal of medicine, 2021-12, Vol.385 (27), p.2531-2543

2021

Volltextzugriff (PDF)

HIV Infection and Long-Term Residual Cardiovascular Risk After Acute Coronary Syndrome

Journal of the American Heart Association, 2020-09, Vol.9 (17), p.e017578

2020

Volltextzugriff (PDF)

Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial

Journal of acquired immune deficiency syndromes (1999), 2012-04, Vol.59 (5), p.489

2012

Volltextzugriff (PDF)

Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions

AIDS (London), 2013-02, Vol.27 (4), p.579-589

2013

Volltextzugriff (PDF)

Air Temperature and Inflammatory Responses in Myocardial Infarction Survivors

Epidemiology (Cambridge, Mass.), 2008-05, Vol.19 (3), p.391-400

2008

Volltextzugriff (PDF)

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies

Journal of antimicrobial chemotherapy, 2015-07, Vol.70 (7), p.2084-2089

2015

Volltextzugriff (PDF)

Ambient Air Pollution and Daily Mortality Among Survivors of Myocardial Infarction

Epidemiology (Cambridge, Mass.), 2009-01, Vol.20 (1), p.110-118

2009

Volltextzugriff (PDF)

Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial

The Pediatric infectious disease journal, 2003-01, Vol.22 (1), p.56-62

2003

Volltextzugriff (PDF)

Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy

AIDS (London), 2006-11, Vol.20 (17), p.2183-2191

2006

Volltextzugriff (PDF)

Once vs. twice-daily lopinavir/ritonavir in HIV-1-infected children

AIDS (London), 2015-11, Vol.29 (18), p.2447-2457

2015

Volltextzugriff (PDF)

Interstitial Radiosurgery with the Photon Radiosurgery System in the Minimally-Invasive Treatment of Selected Deep-Seated Brain Tumors

Journal of chemotherapy (Florence), 2004-11, Vol.16 (sup5), p.70-74

2004

Volltextzugriff (PDF)

Fibrinogen Genes Modify the Fibrinogen Response to Ambient Particulate Matter

American journal of respiratory and critical care medicine, 2009-03, Vol.179 (6), p.484-491

2009

Volltextzugriff (PDF)

Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV‐infected infants and toddlers

British journal of clinical pharmacology, 2012-04, Vol.73 (4), p.641-650

2012

Volltextzugriff (PDF)

Response to planned treatment interruptions in HIV infection varies across childhood

AIDS (London), 2010-01, Vol.24 (2), p.231-241

EUROPEAN, Paediatric

2010

Volltextzugriff (PDF)

DNA variants, plasma levels and variability of Interleukin-6 in myocardial infarction survivors: Results from the AIRGENE study

Thrombosis research, 2009-05, Vol.124 (1), p.57-64

2009

Volltextzugriff (PDF)

Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission

Antiviral therapy, 2004-06, Vol.9 (3), p.415-421

2004

Volltextzugriff (PDF)

Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus—Infected Patients

Clinical infectious diseases, 2002-03, Vol.34 (5), p.649-657

2002

Volltextzugriff (PDF)

Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1

The Pediatric infectious disease journal, 2003-01, Vol.22 (1), p.48-55

2003

Volltextzugriff (PDF)

Plasma Drug Concentrations and Virologic Evaluations after Stopping Treatment with Nonnucleoside Reverse-Transcriptase Inhibitors in HIV Type 1–Infected Children

Clinical infectious diseases, 2008-05, Vol.46 (10), p.1601-1608

2008

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(89)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A nested case-control study on dietary fat consumption and the risk for gallstone disease

Gamma Knife Radiosurgery in the management of single and multiple brain metastases

Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome

Sex differences among subcutaneous implantable cardioverter-defibrillator recipients: a propensity-matched, multicentre, international analysis from the i-SUSI project

Follow-up for 3 years of a pediatric population diagnosed in 2018 with mother-to-child transmission of HIV in 8 Latin American countries in the PLANTAIDS cohort

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

HIV Infection and Long-Term Residual Cardiovascular Risk After Acute Coronary Syndrome

Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial

Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions

Air Temperature and Inflammatory Responses in Myocardial Infarction Survivors

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies

Ambient Air Pollution and Daily Mortality Among Survivors of Myocardial Infarction

Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial

Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy

Once vs. twice-daily lopinavir/ritonavir in HIV-1-infected children

Interstitial Radiosurgery with the Photon Radiosurgery System in the Minimally-Invasive Treatment of Selected Deep-Seated Brain Tumors

Fibrinogen Genes Modify the Fibrinogen Response to Ambient Particulate Matter

Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV‐infected infants and toddlers

Response to planned treatment interruptions in HIV infection varies across childhood

DNA variants, plasma levels and variability of Interleukin-6 in myocardial infarction survivors: Results from the AIRGENE study

Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission

Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus—Infected Patients

Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1

Plasma Drug Concentrations and Virologic Evaluations after Stopping Treatment with Nonnucleoside Reverse-Transcriptase Inhibitors in HIV Type 1–Infected Children

Aktive Filter

Suchergebnisse filtern